Janus Henderson Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-134,617
| Closed | -$15.6M | – | 2653 |
|
|
2023
Q3 | $15.6M | Buy |
134,617
+32,517
| +32% | +$3.49M | 0.01% | 581 |
|
|
2023
Q2 | $10.5M | Sell |
102,100
-1,636,046
| -94% | -$173M | 0.01% | 684 |
|
|
2023
Q1 | $190M | Sell |
1,738,146
-2,211,373
| -56% | -$244M | 0.13% | 169 |
|
|
2022
Q4 | $449M | Sell |
3,949,519
-8,124,517
| -67% | -$675M | 0.32% | 78 |
|
|
2022
Q3 | $747M | Buy |
12,074,036
+4,637,426
| +62% | +$324M | 0.28% | 90 |
|
|
2022
Q2 | $593M | Buy |
7,436,610
+268,993
| +4% | +$25.5M | 0.41% | 51 |
|
|
2022
Q1 | $754M | Buy |
7,167,617
+115,429
| +2% | +$11.2M | 0.36% | 63 |
|
|
2021
Q4 | $760M | Buy |
7,052,188
+998,456
| +16% | +$109M | 0.32% | 72 |
|
|
2021
Q3 | $663M | Buy |
6,053,732
+229,538
| +4% | +$23.8M | 0.29% | 79 |
|
|
2021
Q2 | $545M | Sell |
5,824,194
-1,772,963
| -23% | -$163M | 0.23% | 105 |
|
|
2021
Q1 | $699M | Sell |
7,597,157
-595,464
| -7% | -$50.2M | 0.32% | 77 |
|
|
2020
Q4 | $599M | Sell |
8,192,621
-745,532
| -8% | -$55.4M | 0.28% | 82 |
|
|
2020
Q3 | $694M | Buy |
8,938,153
+580,629
| +7% | +$40M | 0.36% | 60 |
|
|
2020
Q2 | $465M | Buy |
8,357,524
+1,674,602
| +25% | +$71.6M | 0.26% | 87 |
|
|
2020
Q1 | $198M | Buy |
6,682,922
+807,303
| +14% | +$27.3M | 0.14% | 162 |
|
|
2019
Q4 | $213M | Buy |
+5,875,619
| New | +$180M | 0.11% | 209 |
|
Other funds holding HZNP
IA
BTI
VWA
FSWA
BCMLT
HNB